Abstract
IN THE LATEST leadership changes among big pharma firms, both Sanofi-Aventis and Merck KGaA have unveiled new appointments to their executive suites As of Jan. 1, 2011, former National Institutes of Health director Elias A. Zerhouni will take over for Marc Cluzel as head of RD ...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
